Ukscholarships
Menu

Imperial College London MRes in Clinical Research – Translational Medicine bursaries 2025

Subscribe for Scholarship Alert.

The NIHR Imperial BRC is delighted to be able to award up to three bursaries to home fee status participants of the MRes in Clinical Research – Translational Medicine pathway programme for the 2025-20026 academic year. Bursaries are available to those currently holding an offer for the 25-26 academic year to start the MRes Clinical Research  (Translational Medicine pathway).

Table of Content

Summary

Benefits

Up to 3 bursaries are offered to home fee-paying students. Each bursary is valued at £7,450, which is applied for the 1-year programme.

Requirements

To receive the bursary, you must 

  • Accepted the offer and have fulfilled all offer criteria.
  • Home status fee-paying students whose aim is to complete the full MRes over 1 year. 

To be eligible to apply the applicant must be in receipt of an offer for the MRes Clinical Research – Translational Medicine to commence in October 2025.

Please note: This scholarship is not available to continuing students.

Application Deadline

August 22, 2025

How To Apply

To be eligible to apply the applicant must be in receipt of an offer for the MRes Clinical Research – Translational Medicine to commence in October 2025.

Application process

  • Apply online for the MRes Clinical Research – Translational Medicine pathway programme.
  • Include a 1-page personal statement outlining your reasons for undertaking the programme and how it will benefit your career. Clearly label the top of your personal statement with: "BRC Funding Opportunity".
  • Your programme application will also serve as your application for the bursary. No separate funding application is required.
  • Submit your application by Friday, 22nd August 2025, 12:00 pm (UK time).

For more details, visit Imperial College London scholarship webpage.

Share

A friend or someone might be interested in this opportunity, kindly share.

Subscribe for scholarship alert.